(Q44512394)

3 December 2017

title

Kinetic properties of human thymidylate synthase, an anticancer drug target (English)

1 reference

3 December 2017

Oksana A Sergeeva

1

1 reference

3 December 2017

H Godrej Khambatta

series ordinal

2

1 reference

3 December 2017

Brian E Cathers

series ordinal

3

1 reference

3 December 2017

Maria V Sergeeva

series ordinal

4

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Biochemical and Biophysical Research Communications

3 December 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

3 December 2017

volume

307

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

297-300

1 reference

Determinants of prognosis and response to therapy in colorectal cancer

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901173-2

Comparison of 5-fluoro-2'-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901173-2

Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901173-2

Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901173-2

Cellular transformation of the investigational new anticancer drug NB1011, a phosphoramidate of 5-(2-bromovinyl)-2'-deoxyuridine, results in modification of cellular proteins not DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2901173-2

10.1016/S0006-291X(03)01173-2

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference